| Rebecca L Ritter, NP-C | |
|
1000 E Rosser Ave, Bismarck, ND 58501-4414 | |
| (701) 530-6000 | |
| (701) 530-6430 |
| Full Name | Rebecca L Ritter |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Location | 1000 E Rosser Ave, Bismarck, North Dakota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013964527 | NPI | - | NPPES |
| 19589 | Medicaid | ND | |
| 970000520 | Other | ND | MEDICARE RAILROAD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | R22796 (North Dakota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Rebecca L Ritter, NP-C 401 N 9th St, Bismarck, ND 58501-4507 Ph: (701) 530-6000 | Rebecca L Ritter, NP-C 1000 E Rosser Ave, Bismarck, ND 58501-4414 Ph: (701) 530-6000 |
News Archive
Savient Pharmaceuticals, Inc. and its wholly owned subsidiary, Savient Pharma Ireland Limited, announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has completed its scientific assessment and has issued a positive opinion recommending approval of a marketing authorization in the European Union for KRYSTEXXA for the treatment of severe debilitating chronic tophaceous gout in adult patients who may also have erosive joint involvement and who have failed to normalize serum uric acid with xanthine oxidase inhibitors at the maximum medically appropriate dose or for whom these medicines are contraindicated.
Reports suggest that nearly 100,000 women in Britain have undergone female genital mutilations. Even medics in the UK are offering to carry out the illegal procedure on girls as young as 10.
Researchers at Purdue University have created a magnetic "ferropaper" that might be used to make low-cost "micromotors" for surgical instruments, tiny tweezers to study cells and miniature speakers.
The targeted drug trastuzumab, or Herceptin, previously shown to prolong survival in advanced breast cancer, dramatically reduced the chances of recurrence in patients with early-stage disease when given for one year following standard chemotherapy.
› Verified 5 days ago
Sarah Miller, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 222 N 7th St, Bismarck, ND 58501 Phone: 701-323-5422 Fax: 701-323-8645 | |
Danette Pengilly, GNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 310 N 10th St, Bismarck, ND 58501 Phone: 701-530-7500 Fax: 701-530-7484 | |
Jana Rakowski, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1040 Tacoma Ave, Bismarck, ND 58504 Phone: 701-323-7452 Fax: 701-323-6982 | |
Mrs. Christina R Gisvold, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 300 N 7th St, Bismarck, ND 58501 Phone: 701-323-6000 | |
Lee Ann June Short, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 300 N 7th St, Bismarck, ND 58501 Phone: 701-204-1709 | |
Cheryle K Bitz, MSN, ARNP, GNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 900 E Broadway Ave, Bismarck, ND 58501 Phone: 701-530-7300 Fax: 701-530-7319 |